Literature DB >> 2865952

The metabolism of neuropeptides. Phase separation of synaptic membrane preparations with Triton X-114 reveals the presence of aminopeptidase N.

R Matsas, S L Stephenson, J Hryszko, A J Kenny, A J Turner.   

Abstract

The property of solutions of Triton X-114 to separate into detergent-rich and detergent-poor phases at 30 degrees C has been exploited to investigate the identities of the aminopeptidases in synaptic membrane preparations from pig striatum. When titrated with an antiserum to aminopeptidase N (EC 3.4.11.2), synaptic membranes solubilized with Triton X-100 revealed that this enzyme apparently comprises no more than 5% of the activity releasing tyrosine from [Leu]enkephalin. When assayed in the presence of puromycin, this proportion increased to 20%. Three integral membrane proteins were fractionated by phase separation in Triton X-114. Aminopeptidase activity, endopeptidase-24.11 and peptidyl dipeptidase A partitioned predominantly into the detergent-rich phase when kidney microvillar membranes were so treated. However, only 5.5% of synaptic membrane aminopeptidase activity partitioned into this phase, although the other peptidases behaved predictably. About half of the aminopeptidase activity in the detergent-rich phase could now be titrated with the antiserum, showing that aminopeptidase N is an integral membrane protein of this preparation. Three aminopeptidase inhibitors were investigated for their ability to discriminate between the different activities revealed by these experiments. Although amastatin was the most potent (IC50 = 5 X 10(-7) M) it failed to discriminate between pure kidney aminopeptidase N, the total activity of solubilized synaptic membranes and that in the Triton X-114-rich phase. Bestatin was slightly more potent for total activity (IC50 = 6.3 X 10(-6) M) than for the other two forms (IC50 = 1.6 X 10(-5) M). Puromycin was a weak inhibitor, but was more selective. The activity of solubilized membranes was more sensitive (IC50 = 1.6 X 10(-5) M) than that of the pure enzyme or the Triton X-114-rich phase (IC50 = 4 X 10(-4) M). We suggest that the puromycin-sensitive aminopeptidase activity that predominates in crude synaptic membrane preparations may be a cytosolic contaminant or peripheral membrane protein rather than an integral membrane component. Aminopeptidase N may contribute to the extracellular metabolism of enkephalin and other susceptible neuropeptides in the brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865952      PMCID: PMC1152766          DOI: 10.1042/bj2310445

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  Subcellular localisation of leucine-enkephalin-hydrolysing activity in rat brain.

Authors:  A C Lane; M J Rance; D S Walter
Journal:  Nature       Date:  1977-09-01       Impact factor: 49.962

2.  High-affinity enkephalin-degrading peptidase in brain is increased after morphine.

Authors:  B Malfroy; J P Swerts; A Guyon; B P Roques; J C Schwartz
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

3.  The effect of puromycin on the biological activity of Leu-enkephalin.

Authors:  Z Vogel; M Altstein
Journal:  FEBS Lett       Date:  1979-02-01       Impact factor: 4.124

4.  Is 'enkephalinase' identical with 'angiotensin-converting enzymes'?

Authors:  J P Swerts; R Perdrisot; B Malfroy; J C Schwartz
Journal:  Eur J Pharmacol       Date:  1979-01-01       Impact factor: 4.432

5.  The metabolism of neuropeptides. Endopeptidase-24.11 in human synaptic membrane preparations hydrolyses substance P.

Authors:  R Matsas; M Rattray; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1985-06-01       Impact factor: 3.857

6.  The relationship between enkephalin degradation and opiate receptor occupancy.

Authors:  M Knight; W A Klee
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

7.  Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates.

Authors:  J M Hambrook; B A Morgan; M J Rance; C F Smith
Journal:  Nature       Date:  1976-08-26       Impact factor: 49.962

8.  Enkephalin catabolism in vitro and in vivo.

Authors:  J L Meek; H Y Yang; E Costa
Journal:  Neuropharmacology       Date:  1977-02       Impact factor: 5.250

9.  The metabolic disposition of radiolabeled enkephalins in vitro and in situ.

Authors:  F B Craves; P Y Law; C A Hunt; H H Loh
Journal:  J Pharmacol Exp Ther       Date:  1978-08       Impact factor: 4.030

10.  Studies on the enzymology of purified preparations of brush border from rabbit kidney.

Authors:  S G George; J Kenny
Journal:  Biochem J       Date:  1973-05       Impact factor: 3.857

View more
  31 in total

1.  Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane.

Authors:  N M Hooper; J Keen; D J Pappin; A J Turner
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

2.  Renal dipeptidase is one of the membrane proteins released by phosphatidylinositol-specific phospholipase C.

Authors:  N M Hooper; M G Low; A J Turner
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

Review 3.  The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain.

Authors:  Robert C Speth; Vardan T Karamyan
Journal:  Heart Fail Rev       Date:  2008-01-09       Impact factor: 4.214

4.  Heterogeneity in the human erythrocyte band 3 anion-transporter revealed by Triton X-114 phase partitioning.

Authors:  M L Swanson; R K Keast; M L Jennings; J E Pessin
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

5.  Molecular determinants of species specificity in the coronavirus receptor aminopeptidase N (CD13): influence of N-linked glycosylation.

Authors:  D E Wentworth; K V Holmes
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Heat shock protein and gliadin peptide promote development of peptidase antibodies in children with autism and patients with autoimmune disease.

Authors:  Aristo Vojdani; Mohsen Bazargan; Elroy Vojdani; John Samadi; Alen A Nourian; Navid Eghbalieh; Edwin L Cooper
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

Review 7.  The neovasculature homing motif NGR: more than meets the eye.

Authors:  Angelo Corti; Flavio Curnis; Wadih Arap; Renata Pasqualini
Journal:  Blood       Date:  2008-06-23       Impact factor: 22.113

8.  Identification and characterization of a neutral endopeptidase activity in Aplysia californica.

Authors:  W Bawab; R S Aloyz; P Crine; B P Roques; L DesGroseillers
Journal:  Biochem J       Date:  1993-12-01       Impact factor: 3.857

9.  A fluorimetric assay for aminopeptidase W.

Authors:  M C Jackson; Y Choudry; A Bourne; J F Woodley; A J Kenny
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

10.  Involvement of aminopeptidase N (CD13) in infection of human neural cells by human coronavirus 229E.

Authors:  C Lachance; N Arbour; N R Cashman; P J Talbot
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.